A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia
Abstract As progress in medical interventions for childhood cancer advances, the number of survivors of childhood acute lymphoblastic leukemia (ALL) is rising. Presently, the overall survival rate exceeds 90% over a five-year period. With this upward trend in survival rates, there’s a pressing neces...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-07-01
|
| Series: | Molecular and Cellular Pediatrics |
| Online Access: | https://doi.org/10.1186/s40348-025-00196-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849769133746421760 |
|---|---|
| author | Paige Johnson Ellie Whitney Coleton Evans Donald Beam |
| author_facet | Paige Johnson Ellie Whitney Coleton Evans Donald Beam |
| author_sort | Paige Johnson |
| collection | DOAJ |
| description | Abstract As progress in medical interventions for childhood cancer advances, the number of survivors of childhood acute lymphoblastic leukemia (ALL) is rising. Presently, the overall survival rate exceeds 90% over a five-year period. With this upward trend in survival rates, there’s a pressing necessity to investigate the enduring impacts of childhood cancer treatment. This systematic literature review focuses on the various long term cardiotoxic effects as a result of these treatments. The authors conducted a systematic review to identify studies that evaluated long-term cardiotoxic effects after anthracycline treatments among survivors of childhood ALL via PubMed search engine. Studies were included if ALL survivors were < 21 years old at the time of ALL diagnosis, an average of > 5 years post diagnosis and/or > 120 weeks post completion of consolidation therapy, compared with a healthy control population, and in remission during the assessment. Compared to matched control populations, survivors of childhood ALL had significantly higher rates of diastolic dysfunction and congestive heart failure. Additionally, female sex, younger age at diagnosis, and higher total dosing of anthracyclines administered during treatment led to significantly higher measures of cardiotoxicity. This study underscores the long-term cardiotoxic effects in ALL survivors, primarily linked to anthracycline use. Inconsistent detection of diastolic dysfunction via conventional echocardiogram necessitates regular monitoring of subclinical markers to prevent premature cardiac aging and heart failure. Future research should prioritize longitudinal studies to assess cardiotoxic effects throughout adult ALL survivors’ lifetimes, aiming to establish comprehensive follow-up guidelines. |
| format | Article |
| id | doaj-art-be4806aedac24c66af8e1deeae6bbd8f |
| institution | DOAJ |
| issn | 2194-7791 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Molecular and Cellular Pediatrics |
| spelling | doaj-art-be4806aedac24c66af8e1deeae6bbd8f2025-08-20T03:03:33ZengSpringerOpenMolecular and Cellular Pediatrics2194-77912025-07-0112111110.1186/s40348-025-00196-yA systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemiaPaige Johnson0Ellie Whitney1Coleton Evans2Donald Beam3Anne Burnett Marion School of Medicine at TCUAnne Burnett Marion School of Medicine at TCUAnne Burnett Marion School of Medicine at TCUAnne Burnett Marion School of Medicine at TCUAbstract As progress in medical interventions for childhood cancer advances, the number of survivors of childhood acute lymphoblastic leukemia (ALL) is rising. Presently, the overall survival rate exceeds 90% over a five-year period. With this upward trend in survival rates, there’s a pressing necessity to investigate the enduring impacts of childhood cancer treatment. This systematic literature review focuses on the various long term cardiotoxic effects as a result of these treatments. The authors conducted a systematic review to identify studies that evaluated long-term cardiotoxic effects after anthracycline treatments among survivors of childhood ALL via PubMed search engine. Studies were included if ALL survivors were < 21 years old at the time of ALL diagnosis, an average of > 5 years post diagnosis and/or > 120 weeks post completion of consolidation therapy, compared with a healthy control population, and in remission during the assessment. Compared to matched control populations, survivors of childhood ALL had significantly higher rates of diastolic dysfunction and congestive heart failure. Additionally, female sex, younger age at diagnosis, and higher total dosing of anthracyclines administered during treatment led to significantly higher measures of cardiotoxicity. This study underscores the long-term cardiotoxic effects in ALL survivors, primarily linked to anthracycline use. Inconsistent detection of diastolic dysfunction via conventional echocardiogram necessitates regular monitoring of subclinical markers to prevent premature cardiac aging and heart failure. Future research should prioritize longitudinal studies to assess cardiotoxic effects throughout adult ALL survivors’ lifetimes, aiming to establish comprehensive follow-up guidelines.https://doi.org/10.1186/s40348-025-00196-y |
| spellingShingle | Paige Johnson Ellie Whitney Coleton Evans Donald Beam A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia Molecular and Cellular Pediatrics |
| title | A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| title_full | A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| title_fullStr | A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| title_full_unstemmed | A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| title_short | A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| title_sort | systematic review of long term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia |
| url | https://doi.org/10.1186/s40348-025-00196-y |
| work_keys_str_mv | AT paigejohnson asystematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT elliewhitney asystematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT coletonevans asystematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT donaldbeam asystematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT paigejohnson systematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT elliewhitney systematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT coletonevans systematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia AT donaldbeam systematicreviewoflongtermcardiotoxiceffectsoftreatmentinsurvivorsofchildhoodacutelymphoblasticleukemia |